Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-12-06 11:52 am Sale | 13D | INNATE PHARMA S A SPONSORED AD IPHA | Bpifrance Participations SA | 7,186,628 9% | -801,741 (-10.04%) | View |
| 2022-10-21 12:58 pm Sale | 13D | INNATE PHARMA S A SPONSORED AD IPHA | Bpifrance Participations SA | 7,988,369 10% | -964,098 (-10.77%) | View |
| 2021-02-12 2:35 pm Purchase | 13D | INNATE PHARMA S A SPONSORED AD IPHA | Bpifrance Participations SA | 8,952,467 11.3% | 8,952,467 (New Position) | View |
| 2020-02-03 07:00 am Purchase | 13G | INNATE PHARMA S A SPONSORED AD IPHA | NOVO NORDISK A S NVO | 9,817,546 12.5% | 9,817,546 (New Position) | View |
| 2019-10-25 2:36 pm Purchase | 13D | INNATE PHARMA S A SPONSORED AD IPHA | ASTRAZENECA PLC AZN | 7,485,500 9.5% | 7,485,500 (New Position) | View |
| 2019-10-23 4:08 pm Purchase | 13G | INNATE PHARMA S A SPONSORED AD IPHA | EcoR1 Capital LLC | 6,623,114 8.4% | 6,623,114 (New Position) | View |